ACTRN12619000692134招募中未知
Safety and feasibility trial of motor cortex stimulation via an external pulse generator in order to augment rehabilitation in individuals post stroke
Professor John Reynolds0 个研究点目标入组 24 人开始时间: 2019年5月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •To be included in the study, participants must meet all of the following inclusion criteria:
- •1.Capable of understanding and signing an informed consent form
- •2.Have a cortical or subcortical stroke at least 4 months earlier, screened by prior CT/MRI and verified by study MRI
- •3.Aged at least 18 years on the day of consent
- •4.Confirmation of intact cortical tracts by the presence of a TMS-elicited MEP recorded from the paretic upper limb.
- •5.Been assessed by Physiotherapy and deemed suitable (likely to be able to participate in 80% or more of the 11 weeks of three-days-a-week of physiotherapy sessions).
排除标准
- •To be included in the study, participants must meet none of the following exclusion criteria:
- •1.History of epileptic seizures
- •2.Participants with pacemakers/defibrillators
- •3.Participants who have contraindications for MRI and TMS
- •4.Female participants who are or intend to become pregnant
- •5.Participants who, in the opinion of the investigators, do not understand the information and procedures of the study, or would not be compliant with them (in particular the study restrictions and risks involved).
- •6.Participants who have pain, significant musculotendinous or bony restrictions of the affected upper limb, chronic disease (other than stroke) that will independently cause significant disability or weakness of the affected upper limb.
- •7.Any participant for whom the investigators believe, for any reason, that participation would not be an acceptable risk.
研究者
相似试验
招募中
1 期
Implanted (brain) Stimulators to Augment stroke Rehabilitation Therapy (iSTART trial)StrokeACTRN12616000029493Ministry of Business, Innovation and Employment20
终止
3 期
CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic PainPain, IntractableFacial PainNCT00122915MedtronicNeuro104
Unknown
1 期
Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson DiseaseParkinson DiseaseNCT00159172Assistance Publique - Hôpitaux de Paris10
终止
1 期
Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive DisorderDepressive DisorderDepressionNCT00380042Northstar Neuroscience12
终止
1 期
Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.Trigeminal Neuralgia (Burchiel Type I)Trigeminal Neuralgia (Burchiel Type II)Trigeminal Neuropathic PainTrigeminal Deafferentation PainComplex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity)Glossopharyngeal NeuralgiaUpper Extremity Pain Due to Deafferentation of the Cervical SpineCentral Pain SyndromesNCT02321566Johns Hopkins University1
